0
0
58 words
0
Comments
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches t…
You are the first to view
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08621-1
Create an account or login to join the discussion